Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation

New Microbiologica

Volumn 33, Issue 3, 2010, Pages 263-265

  Gabrielli, Eugenia ^a   Ferraioli, Giovanna ^b   Ferraris, Laurenzia ^a   Riva, Agosfno ^a   Galii, Massimo ^a   Filice, Carlo ^b   Gervasoni, Cristina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Enfuvirtide; Silicon oil; Ultrasound

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ENFUVIRTIDE; GLYCOPROTEIN GP 41; PEPTIDE FRAGMENT; SILICONE OIL;

ADULT; ARTICLE; BREAST ENDOPROSTHESIS; CASE REPORT; ECHOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SUBCUTANEOUS TISSUE; TRANSSEXUALISM; BREAST IMPLANT; HIV INFECTIONS;

ADULT; ANTI-HIV AGENTS; BREAST IMPLANTS; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; MALE; PEPTIDE FRAGMENTS; SILICONE OILS; SUBCUTANEOUS TISSUE; TRANSSEXUALISM;

EID: 77957038793     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. BALL R.A., KINCHELOW T. (2003). Injection site reactions with the HIV-I fusion inhibitor enfuvirtide. J. Am. Acad. Dermatol. 49, 826-831.
2. BIENVENU B., KRIVINĚ A., ROLLOT F., ET AL. (2006). A cohort study of enfuvirtide immunological and virological efficacy in clinical practice. 7. Med. Virol. 78, 1312-1317. (Pubitemid 44387517)
3. CLOTET B., RAFFI E, COOPER D., ET AL. (2004). Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations. AIDS. 18, 1137-1146.
4. HARRIS K.M., GANOTTM.A., SHESTAK K.C., LOSKEN H.W., TOBON H. (1993) Silicone implant rupture: detection with US. Radiology. 187, 761-768.
5. LUTHER J., GLESBY M.J. (2007). Dermatologie adverse effects of antiretroviral therapy: recognition and management. Am. J. Clin. Dermatol. 8, 221-233. (Pubitemid 47195666)
6. ROSCULET K.A., IKEDA D.M., FORREST M.E., ET AL. (1992). Ruptured gel-filled silicone breast implants: sonographic findings in 19 cases. AJR Am. J. Roentgenol. 159,711-716.
7. RUBIN J.M., HELVIE M.A., ADLER R.S., IKEDA D. (1994). US appearance of ruptured silicone breast implants. Radiology. 190, 583.
8. SHAUT P., TRUE A., THOMMES J.A. (2007). Quality of life and tolerability after administration of enfuvirtide with a thin-walled needle: QUALITE Study. HIV Clin. Trials. 8, 24-35.
9. TROTTIER B., WALMSLEY S., REYNES J., ET AL. (2005). Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment experienced HIV-I-infected adults over 48 weeks. 7. Acquir. Immune Defic. Syndr. 40, 413-421.
10. SCARANELO A.M., DE FÁTIMA RIBEIRO MAIA M. (2006). Sonographic and mammographie findings of breast liquid silicone injection. 7. Clin. Ultrasound. 34, 273-277.